Intensified generic-based management in Korean pharmaceutical industry
Korean pharmaceutical companies were criticized to still manage their business relying on generic drugs. 3 of 4 medicines approved this year were ETC, and most ETC drugs were reportedly generics Korean pharmaceutical companies acquired approval.
According to the Ministry of Food and Drug Safety(...
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.